USPTO serial 79245112
EXCELLA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 8, 2021
- Examiner
- O'BRIEN, JENNIFER LYNN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with EXCELLA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
THOMAS E ZUTIC
THOMAS E ZUTIC DLA PIPER LLP (US)500 8TH ST NWWASHINGTON, DC 20004UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 040 | Food preservation services, namely, food and beverage preservation; preservation of medicines in tablet form, capsule form, granule form, pellet form, and powder form that is not reconstituted for injection, namely, cryogenic preservation; pattern printing; Providing technical information in the field of the processing of food, drinks and medicines in the nature of providing technical information in the field of manufacturing active pharmaceutical ingredients and pharmaceuticals in tablet form, capsule form, granule form, pellet form, and powder form that is not reconstituted for injection; treatment of gases, solids and liquids for packaging, bottling, bagging or packing thereof, namely, treatment of materials by means of laser beams, cryogenic processing, Fuel treatment services, Metal treatment, Nuclear waste treatment; treatment of mixtures of gases, solids and liquids for packaging, bottling, bagging, wrapping or conditioning thereof, namely, Treatment of materials by means of laser beams, cryogenic processing, Fuel treatment services, Metal treatment, Nuclear waste treatment; Decorative pattern printing on wrapping paper; printing of decorative patterns on paper packaging and plastic films; custom manufacture of pharmaceutical, cosmetic, industrial and household products, namely, custom manufacture of active pharmaceutical ingredients and pharmaceuticals in tablet form, capsule form, granule form, pellet form, and powder form that is not reconstituted for injection, chemotherapy drugs in tablet form, capsule form, granule form, pellet form, and powder form that is not reconstituted for injection, antibiotic medicines in tablet form, capsule form, granule form, pellet form, and powder form that is not reconstituted for injection by pharmaceutical compounders and custom manufacture of furniture, containers, drapery; custom manufacture of fragrances; custom manufacture of medical devices for others, excluding medical devices containing pharmaceuticals that are in powder form reconstituted for injection or that are not in tablet form, not in capsule form, not in granule form, or not in pellet form; custom mold manufacturing services for use in industry; prototype manufacture of new third-party products for research and technical development of products, namely, prototype fabrication of new products for others, excluding products containing pharmaceuticals that are in powder form reconstituted for injection or that are not in tablet form, not in capsule form, not in granule form, or not in pellet form; custom manufacture of machines and tools for compressing and compacting powders and granules; application of thin films on object surfaces in the nature of treatment of materials by means of chemical, mechanical, thermal, thermomechanical processes, chemical vapor deposition, physical vapor deposition and vacuum deposition; application of coatings in the nature of treatment of materials by means of chemical, mechanical, thermal or thermo-mechanical processes; paper finishing; custom assembly of materials for others, namely, assembly of products for others, excluding products containing pharmaceuticals that are in powder form reconstituted for injection or that are not in tablet form, not in capsule form, not in granule form, or not in pellet form; custom assembly of composite and plastic parts for others; Providing information relating to the treatment of materials; custom perfume mixing services, namely, custom manufacture of perfume; treatment of hazardous liquids; treatment of materials upon third-party request by means of laser beams, cryogenic processing; treatment of biopharmaceuticals in tablet form, capsule form, granule form, pellet form, and powder form that is not reconstituted for injection, pharmaceuticals in tablet form, capsule form, granule form, pellet form, and powder form that is not reconstituted for injection, active pharmaceutical ingredients, cosmetic materials and chemical materials by means of laser beams, cryogenic processing; treatment of medicinal materials in tablet form, capsule form, granule form, pellet form, and powder form that is not reconstituted for injection medicinal materials in the nature of active pharmaceutical ingredients, and cosmetic materials by means of laser beams, cryogenic processing; processing of chemicals; processing of chemical and petrochemical products, namely, processing of fuel materials, processing of oil, gas processing services; none of the foregoing related to pharmaceuticals in table form, capsule form, granule form, pellet form, and powder form that is not reconstituted for injection | ACTIVE | — |
| 042 | Industrial research, testing and analysis services in the field of physics, bacteriology; biological research services; medical research; biochemical research; biotechnological research services; cosmetic research services; engineering research services; mechanical research; technological research services in the field of medical instruments, video surveillance equipment; scientific research, development and analysis; technical research projects and studies in the field of home care, cosmetics, food; research in the field of hair care; research and development in the field of biotechnology; bacteriological research services; research, development and analysis services in the field of chemistry and biology; research in the field of environmental preservation; laboratory research and analysis services in the field of bacteriology, chemistry, cosmetics; preparation of reports relating to scientific research, namely, scientific study and research in the field(s) of medicine, the prevention, treatment and management of illness, health care delivery; preparation of reports relating to technical research, namely, technical research in the field of home care, cosmetics, food; preparation of reports relating to technological research, namely, technological research in the field of home care, cosmetics, food; services provided by consultants in the field of pharmaceuticals research, namely, research regarding active pharmaceutical ingredients and pharmaceuticals in tablet form, capsule form, granule form, pellet form, and powder form that is not reconstituted for injection; services provided by consultants in the field of scientific research; services provided by consultants in the field of technological research in the field of aerospace engineering, geology; research and development services in the field of bacteriology; research and development services in the field of cytology; research and development services in connection with physics; scientific research, testing and analysis services in the field of home care, cosmetics, food; provision of technical advice in the field of scientific and industrial research in the field of home care, cosmetics, food; scientific research relating to hair care preparations; services provided by consultants relating to research and development in the field of therapeutics; provision of information about industrial analysis and research services in the field of home care, cosmetics, food; provision of information relating to medical and scientific research in the field of pharmaceutical products, namely, research regarding active pharmaceutical ingredients and pharmaceuticals in tablet form, capsule form, granule form, pellet form, and powder form that is not reconstituted for injection; provision of information and data relating to medical and veterinary scientific research and development; provision of information and data relating to scientific and technological research and development in the field of home care, cosmetics, food; services provided by consultants and research in the field of engineering and information technology; services provided by consultants relating to research services in the field of foods and dietary supplements; none of the foregoing related to pharmaceuticals other than active pharmaceutical ingredients and pharmaceuticals in tablet form, capsule form, granule form, pellet form, and powder form that is not reconstituted for injection | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Excella GmbH & Co. KG
- Other trademarks owned by Excella GmbH & Co. KG
- Other trademarks owned by Excella GmbH & Co. KG
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named EXCELLA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 8, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jun 4, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 24, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 29, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 29, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 8, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 8, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 1, 2021 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| May 1, 2021 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| May 1, 2021 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Mar 26, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 24, 2020 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 8, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 8, 2020 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 31, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 11, 2020 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Jan 3, 2020 | OPNS | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB | — |
| Jan 3, 2020 | OPNC | OPPOSITION NOTICE (IB REFUSAL) CREATED | — |
| Oct 2, 2019 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Sep 3, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 3, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 30, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 14, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 14, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 14, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 31, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jul 23, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 4, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 3, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 3, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 3, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 3, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 25, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 8, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 8, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 21, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 20, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 15, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 13, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 9, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 8, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |